Landscapes / Targets
A2BR
2 drugs act on A2BR, in 2 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Dec 2028Phase 1/2 trial completes | |||
| Next date | 1 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Renal Cell Cancer, Castrate Resistant Prostate Cancer and 2 more | ||||
| Open drug page | |||||
— |
Gilead (Kite) · Public GILD |
Phase 2 | Sep 2029Phase 2 trial completes | ||
| Next date | Sep 2029 · Phase 2 trial completes | ||||
| Also tested for | Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026